Skip to main content

Table 1 List of the oligonucleotides used in the study

From: A novel target enrichment strategy in next-generation sequencing through 7-deaza-dGTP-resistant enzymatic digestion

Oligonucleotide

Polarity

Sequence (5′ → 3′)

Position

Product size/note

HBVF1

Sense

actctctcgtccccttctcc

1479–1498

504 bp

HBVR1

Antisense

tgacggaaggaaagaagtcag

1962–1982

HBVR1p

Antisense

ptgacggaaggaaagaagtcag

1962–1982

HBVF2

Sense

ccttctccgtctgccgttc

1491–1509

488 bp

HBVR2

Antisense

ggaaggaaagaagtcagaaggc

1957–1978

HBVF3

Sense

aacaggctttcactttctcgc

1082–1102

1311 bp

HBVR3

Antisense

cgagggagttcttcttctaggg

2371–2392

HBVR4

Antisense

ptccacactccgaaagagacc

2257–2276

 

Splinter

NA

nnnnnnaggtgtgtSp3

To facilitate intramolecular ligation

HBVR5

Antisense

tgtgtg*g*a

Target-specific RCA

C28

NA

Sp18nnn*n*n

Non-specific RCA

  1. Position is according to the full-length HBV genome under GenBank accession number AB241115. Star donated phosphorothioate bonds to resist exonuclease activity of phi29 DNA polymerase. P in superscript indicated the modification of phosphate at the 5′ ends. C28 is the primer to eliminate primer-mediated artifacts from phi29 DNA polymerase-based multiple displacement amplification in our previous study [11]. Sp3, C3 spacer to block self-ligation of the splinter; Sp18, C18 spacer; NA, not applicable. All oligonucleotides were ordered from the Integrated DNA Technologies, Coralville, IA